95% CI, 0.86-0.98) and a 20% lower risk for death due to any cause (HR = 0.8
The most common adverse events associated with tirzepatide were nausea, constipation, and nasopharyngitis, with a low frequency of gastrointestinal events
In children, it is used to promote height gain, while in adults, it is used to maintain muscle mass, reduce fat accumulation, and support overall health
Over a period of 4 to 8 weeks, as you move from the initial titration doses to higher therapeutic levels, the decrease in hunger becomes a steady state rather than a fluctuating feeling
Oral supplements must survive stomach acid, intestinal absorption, and liver first-pass metabolism before reaching your bloodstream